Study explores women’s interest in long-acting injectable antiretroviral therapy – News-Medical.Net

A study led by Columbia University Mailman School of Public Health researchers examines attitudes toward long-acting injectable (LAI) HIV therapies, among women with a history of injection–including medical purposes and substance use. The findings appear in the journal AIDS Patient Care and STDs.
Currently, most HIV therapies for treatment and prevention (pre-exposure prophylaxis, PrEP) necessitate daily pills, which pose barriers to adherence. Recently, however, LAI for HIV has emerged as an alternative…

Click here to view the original article.